Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00670397
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute 11
Testing effectiveness (Phase 2)UnknownNCT01086488
What this trial is testing

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Ministry of Health, Malaysia 66
Testing effectiveness (Phase 2)Study completedNCT03993353
What this trial is testing

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+9 more
University of California, San Diego 7
Not applicableUnknownNCT04170257
What this trial is testing

Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal Lesions

Who this might be right for
Mild Dysplasia of EsophagusModerate Dysplasia of EsophagusSevere Dysplasia of Esophagus+2 more
Peking University Cancer Hospital & Institute 10,000
Testing effectiveness (Phase 2)Study completedNCT00238407
What this trial is testing

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT02759575
What this trial is testing

Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Vinita Takiar 9
Not applicableActive Not RecruitingNCT04151134
What this trial is testing

Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Ended earlyNCT03440437
What this trial is testing

FS118 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerSquamous Cell Carcinoma of Head and Neck
invoX Pharma Limited 80
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)UnknownNCT05145907
What this trial is testing

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Who this might be right for
Triple-negative Breast CancerHead and Neck Squamous Cell Carcinoma
TJ Biopharma Co., Ltd. 133
Early research (Phase 1)Ended earlyNCT02110992
What this trial is testing

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
University of Cincinnati 7
Testing effectiveness (Phase 2)Study completedNCT00423930
What this trial is testing

Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 44
Not applicableLooking for participantsNCT05621837
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
MelanomaBreast CancerRenal Cell Carcinoma+4 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1,000
Not applicableStudy completedNCT00002695
What this trial is testing

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 530
Early research (Phase 1)Study completedNCT00625456
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

Who this might be right for
MelanomaLung CancerRenal Cell Carcinoma+1 more
Jennerex Biotherapeutics 23
Testing effectiveness (Phase 2)Looking for participantsNCT06657222
What this trial is testing

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHNSCCSCLC+3 more
Tubulis GmbH 250
Testing effectiveness (Phase 2)WithdrawnNCT03325465
What this trial is testing

Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT07791602
What this trial is testing

Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck CancerHNSCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Next Page